Precision Medicine Solutions
At Covance, our mission is to improve patients’ health and lives.
With nearly half of all new therapy approvals classified as precision medicines, this approach has not only already had a tremendous impact on patients’ lives, but also holds great promise for the future of medicine. Whether from a highly targeted therapy, such as cell and gene therapies or biologics or through biomarkers, genomics testing and Companion Diagnostics to define clinically relevant indicators, we can help you discover, develop and commercialize your next precision medicine.
Highly targeted therapies paired with biomarker-driven drug development strategies provide a path for translational medicine success. You need a sponsor and patient-centric CRO partner that can be with you every step of the journey.
- Deploy personalized medicine strategies throughout development to increase your therapeutic candidate’s probability of success
- Utilize biomarkers in preclinical and clinical development for key and timely insights to make more informed decisions
- Co-develop your therapeutic candidate with a companion diagnostic to maximize uptake and competitive advantage